KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Exchange Rate Effect (2016 - 2025)

Abbott Laboratories' Exchange Rate Effect history spans 17 years, with the latest figure at $6.0 million for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 107.23% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $71.0 million, up 173.96%, while the annual FY2025 figure was $71.0 million, 173.96% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $6.0 million at Abbott Laboratories, up from -$10.0 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $51.0 million in Q4 2022 and bottomed at -$96.0 million in Q3 2022.
  • The 5-year median for Exchange Rate Effect is -$11.5 million (2021), against an average of -$12.0 million.
  • The largest YoY upside for Exchange Rate Effect was 492.31% in 2022 against a maximum downside of 1875.0% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at -$13.0 million in 2021, then soared by 492.31% to $51.0 million in 2022, then plummeted by 50.98% to $25.0 million in 2023, then tumbled by 432.0% to -$83.0 million in 2024, then skyrocketed by 107.23% to $6.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Exchange Rate Effect are $6.0 million (Q4 2025), -$10.0 million (Q3 2025), and $51.0 million (Q2 2025).